Author | Halbedl, Sonja | dc.contributor.author |
Author | Schoen, Michael | dc.contributor.author |
Author | Feiler, Marisa S. | dc.contributor.author |
Author | Böckers, Tobias M. | dc.contributor.author |
Author | Schmeisser, Michael J. | dc.contributor.author |
Date of accession | 2018-09-25T08:53:24Z | dc.date.accessioned |
Available in OPARU since | 2018-09-25T08:53:24Z | dc.date.available |
Date of first publication | 2016 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | axon | dc.subject |
Keyword | NMDA receptor | dc.subject |
Keyword | Shank1 | dc.subject |
Keyword | Shank2 | dc.subject |
Keyword | Shank3 | dc.subject |
Keyword | synapse | dc.subject |
Keyword | postsynaptic density proteins | dc.subject |
Keyword | synaptic proteins | dc.subject |
Keyword | binding-protein | dc.subject |
Keyword | growth cones | dc.subject |
Keyword | mutant mice | dc.subject |
Keyword | family | dc.subject |
Keyword | expression | dc.subject |
Keyword | autism | dc.subject |
Keyword | mutations | dc.subject |
Keyword | cortactin | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | Shank3 is localized in axons and presynaptic specializations of developing hippocampal neurons and involved in the modulation of NMDA receptor levels at axon terminals | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Faculty | Medizinische Fakultät | uulm.affiliationGeneral |
Institution | Institut für Anatomie und Zellbiologie | uulm.affiliationSpecific |
Institution | Internationale Graduiertenschule für Molekulare Medizin | uulm.affiliationSpecific |
Institution | UKU. Klinik für Neurologie | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
DOI (external) | 10.1111/jnc.13523 | dc.identifier.doiExternal |
Source - Title of source | Journal of Neurochemistry | source.title |
Source - Place of publication | Wiley-Blackwell | source.publisher |
Source - Volume | 137 | source.volume |
Source - Issue | 1 | source.issue |
Source - Year | 2016 | source.year |
Source - From page | 26 | source.fromPage |
Source - To page | 32 | source.toPage |
Source - ISSN | 0022-3042 | source.identifier.issn |
Source - eISSN | 1471-4159 | source.identifier.eissn |
Funding | Innovative Medicines Initiative Joint Undertaking [115300] | uulm.funding |
Funding | European Union | uulm.funding |
Funding | EFPIA companies | uulm.funding |
Funding | Baustein 3.2 of Ulm University [L.SBN.0081] | uulm.funding |
Funding | DAAD [PROCOPE 57049403] | uulm.funding |
Funding | Helmholtz Gesellschaft ('RNA Dysmetabolism in ALS and FTD') | uulm.funding |
Funding | Deutsche Forschungsgemeinschaft (DFG) [SBF1149] | uulm.funding |
Funding | Ulm University International Graduate School in Molecular Medicine | uulm.funding |
Open Access | No | uulm.OA |
Suitable community | Medizinische Fakultät | uulm.community |
Suitable community | Zentrale Einrichtungen | uulm.community |
Suitable community | Universitätsklinikum Ulm | uulm.community |
WoS | 000372980100003 | uulm.identifier.wos |
University Bibliography | ja | uulm.unibibliographie |